CMP — Compumedics Income Statement
0.000.00%
- AU$55.81m
- AU$64.40m
- AU$49.72m
- 64
- 66
- 85
- 81
Annual income statement for Compumedics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 35.1 | 35.7 | 37.8 | 42.4 | 49.7 |
Cost of Revenue | |||||
Gross Profit | 18 | 19.2 | 19.3 | 21.6 | 26.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 42.2 | 33.8 | 35.8 | 48.5 | 48.3 |
Operating Profit | -7.08 | 1.91 | 1.93 | -6.11 | 1.4 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -7.5 | 0.776 | 1.7 | -6.72 | 0.48 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.84 | 0.998 | 1.36 | -6.12 | -0.338 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.84 | 0.998 | 1.36 | -6.12 | -0.338 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.84 | 0.998 | 1.36 | -6.12 | -0.338 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.008 | 0.002 | 0.003 | -0.023 | -0.008 |